| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.11B | +58.4% |
| Cost of Revenue | $2.27B | +69.8% |
| Gross Profit | $844.6M | +34.2% |
| R&D Expense | $289.8M | +32.0% |
| SG&A Expense | $112.5M | +36.9% |
| Operating Income | $166.1M | -19.8% |
| Pre-tax Income | $177.2M | -5.4% |
| Income Tax | $83.4M | +361.8% |
| Net Income | $93.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $783.1M | +47.7% |
| Short-term Investments | $241.1M | +43.8% |
| Accounts Receivable | $905.1M | +98.3% |
| Inventory | $729.2M | +91.8% |
| Current Assets | $2.90B | +69.4% |
| Total Assets | $4.27B | +47.5% |
| Current Liabilities | $889.7M | +69.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $31.3M | -85.4% |
| Capital Expenditures | $169.3M | +13.5% |
| Investing Cash Flow | -$417.0M | +13.9% |
| Financing Cash Flow | $654.6M | +4412.9% |
| Free Cash Flow | -$138.1M | -312.8% |
| -44.6% |
| EPS (Basic) | $1.70 | -47.5% |
| EPS (Diluted) | $1.65 | -46.1% |
| Stockholders' Equity |
| $2.18B |
| +66.1% |